- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 111 Huntington Avenue Boston MA United States of America 2199
- IPO Date
- Apr 28, 2006
- Business
- MFS International Growth Fund R6 (MGRDX) is an open-end mutual fund managed by MFS Investment Management that seeks capital appreciation by investing primarily in equity securities of non-U.S. companies with above-average growth potential, strong fundamentals, durable competitive advantages, and reasonable valuations; it employs a multi-cap approach across developed and emerging markets, benchmarked against the MSCI All Country World (ex-US) Growth Index. The fund's portfolio, comprising approximately 85-87 holdings with a weighted average market capitalization of $158-176 billion, emphasizes high-quality growth stocks in sectors including industrials (16-18%), information technology (16-18%), materials (12-13%), financials (12%), health care (12%), consumer discretionary (11-12%), and consumer staples (9-10%); top holdings as of recent periods include Taiwan Semiconductor Manufacturing Co Ltd, SAP SE, Schneider Electric SE, Roche Holding AG, Nestle SA, Hitachi Ltd, AIA Group Ltd, and AstraZeneca PLC. Geographically, the fund allocates across Europe ex-U.K. (38%), emerging markets (20%), the United Kingdom (10-11%), Japan (10%), North America ex-U.S. (11%), and Asia/Pacific ex-Japan (7%), targeting institutional and retirement plan investors with Class R6 shares featuring no sales charge, a net expense ratio of 0.69%, and a low portfolio turnover of 14-17%. Founded in 1924 and headquartered in Boston, Massachusetts, MFS Investment Management, the fund's adviser, operates globally with offices in London, Toronto, Hong Kong, Singapore, Sydney, and Tokyo, managing total net assets exceeding $20 billion for this fund alone. Performance data prior to November 30, 1998, reflects subadvisory by Foreign & Colonial Management Ltd.; recent capital gain distributions occurred in December 2024, including short-term gains of $0.02 per share, long-term gains of $1.90 per share, and dividends of $0.70 per share, with ongoing contractual fee waivers through at least September 30, 2026.